URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Aram Hezel

Concepts (204)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Pancreatic Neoplasms
13
2006
84
3.990
Why?
Biliary Tract Neoplasms
3
2008
6
2.180
Why?
Carcinoma, Pancreatic Ductal
7
2006
15
1.930
Why?
Cholangiocarcinoma
4
2008
13
1.870
Why?
Liver Neoplasms
4
2009
152
1.830
Why?
Protein-Serine-Threonine Kinases
6
2002
285
1.530
Why?
Pancreas
3
2006
124
1.250
Why?
Disease Models, Animal
7
2006
973
1.200
Why?
Gallbladder Neoplasms
3
2010
8
1.180
Why?
Proto-Oncogene Proteins p21(ras)
3
2011
16
1.100
Why?
Phosphatidylinositol 3-Kinases
5
2007
164
1.090
Why?
Tumor Suppressor Protein p53
5
2001
144
1.040
Why?
Carcinoma, Hepatocellular
2
2009
68
0.950
Why?
Integrins
1
2012
48
0.840
Why?
Signal Transduction
9
2005
1626
0.840
Why?
Antigens, Neoplasm
1
2012
107
0.800
Why?
Molecular Targeted Therapy
1
2011
20
0.770
Why?
Radiosurgery
1
2011
74
0.760
Why?
Colorectal Neoplasms
2
2007
136
0.710
Why?
Transforming Growth Factor beta
2
2006
413
0.700
Why?
Cellular Structures
1
2008
3
0.680
Why?
Carcinoma
1
2011
191
0.680
Why?
Genomic Instability
2
2005
20
0.670
Why?
Liver Transplantation
1
2011
238
0.670
Why?
Proto-Oncogene Proteins c-pim-1
1
2008
1
0.670
Why?
Telomere
2
2005
27
0.660
Why?
Genes, ras
6
2001
34
0.650
Why?
Neoplastic Syndromes, Hereditary
1
2008
1
0.640
Why?
Cystadenoma, Serous
1
2008
2
0.640
Why?
Disease Progression
7
2006
519
0.630
Why?
Proto-Oncogene Proteins
4
2007
297
0.610
Why?
Adenocarcinoma
5
2006
423
0.590
Why?
ras Proteins
3
2010
39
0.570
Why?
Mice
17
1999
6103
0.570
Why?
Animals
22
1999
16270
0.560
Why?
Tumor Markers, Biological
1
2008
228
0.560
Why?
Genes, Tumor Suppressor
4
2002
49
0.500
Why?
Antineoplastic Agents
4
2007
625
0.480
Why?
Humans
23
2005
36400
0.480
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
430
0.470
Why?
Mutation
5
2008
1229
0.440
Why?
Protein Kinases
3
2007
126
0.440
Why?
Neoplasms
1
2008
723
0.410
Why?
Bile Ducts, Intrahepatic
2
2011
8
0.410
Why?
Bile Duct Neoplasms
2
2011
14
0.410
Why?
TOR Serine-Threonine Kinases
3
2007
30
0.400
Why?
Deoxycytidine
3
2008
28
0.390
Why?
Indoles
2
2009
104
0.350
Why?
Lung Neoplasms
3
2006
428
0.350
Why?
Aging
1
2005
706
0.330
Why?
Cell Polarity
2
2008
29
0.330
Why?
Peutz-Jeghers Syndrome
2
2002
3
0.280
Why?
Cell Transformation, Neoplastic
3
2002
136
0.280
Why?
Treatment Outcome
4
2007
2623
0.260
Why?
Mice, Mutant Strains
5
1999
126
0.250
Why?
Cyclin-Dependent Kinase Inhibitor p16
4
2001
14
0.250
Why?
Middle Aged
7
2008
9877
0.240
Why?
Gene Deletion
4
2002
205
0.240
Why?
Aged
5
2008
7272
0.220
Why?
Isocitrate Dehydrogenase
1
2011
23
0.210
Why?
Waiting Lists
1
2011
12
0.210
Why?
Tumor Burden
1
2011
23
0.210
Why?
Genetic Engineering
1
2012
22
0.210
Why?
Dose Fractionation
1
2011
58
0.200
Why?
Necrosis
1
2011
105
0.200
Why?
Tumor Suppressor Protein p14ARF
3
2001
6
0.200
Why?
beta Karyopherins
1
2011
14
0.200
Why?
PTEN Phosphohydrolase
1
2011
16
0.200
Why?
Organ Size
1
2011
194
0.200
Why?
Validation Studies as Topic
1
2011
3
0.200
Why?
Tubulin
1
2011
59
0.200
Why?
Mice, Transgenic
3
2008
769
0.190
Why?
Immunohistochemistry
2
2006
1063
0.190
Why?
Cisplatin
1
2011
94
0.190
Why?
DNA Mutational Analysis
1
2011
189
0.180
Why?
Female
8
2007
19826
0.180
Why?
Proto-Oncogene Proteins c-akt
2
2007
134
0.180
Why?
Drug Therapy, Combination
1
2011
390
0.180
Why?
Male
7
2008
19713
0.180
Why?
NF-kappa B
2
2007
443
0.170
Why?
Aged, 80 and over
3
2009
2513
0.170
Why?
MAP Kinase Signaling System
1
2010
96
0.170
Why?
Pyrroles
1
2009
21
0.170
Why?
Amyloid Precursor Protein Secretases
1
2009
12
0.170
Why?
p21-Activated Kinases
1
2008
3
0.170
Why?
Pancreatic Ducts
1
2008
4
0.170
Why?
Mice, Knockout
3
2002
918
0.170
Why?
rho GTP-Binding Proteins
1
2008
23
0.170
Why?
Sirolimus
1
2008
30
0.170
Why?
Liver
2
1999
876
0.160
Why?
Metaplasia
1
2008
19
0.160
Why?
Receptors, Notch
1
2009
62
0.160
Why?
Tight Junctions
1
2008
17
0.160
Why?
Neoplasms, Squamous Cell
1
2008
9
0.160
Why?
Fluorouracil
1
2008
76
0.160
Why?
Islets of Langerhans
1
2008
87
0.150
Why?
Carcinogens
1
2008
62
0.150
Why?
Proto-Oncogene Proteins c-met
1
2007
17
0.150
Why?
Cytoskeleton
1
2008
84
0.150
Why?
Receptors, Growth Factor
1
2007
28
0.150
Why?
Cytokines
1
2011
572
0.150
Why?
Cohort Studies
1
2011
969
0.150
Why?
Antibodies, Monoclonal
1
2011
732
0.150
Why?
Energy Metabolism
1
2008
137
0.150
Why?
Magnesium Compounds
1
2007
5
0.150
Why?
Prednisolone
1
2007
25
0.150
Why?
Smad4 Protein
1
2006
16
0.150
Why?
src-Family Kinases
1
2007
71
0.150
Why?
Calcium Oxalate
1
2007
32
0.140
Why?
Cats
1
2007
216
0.140
Why?
Protein Processing, Post-Translational
1
2008
145
0.140
Why?
Protein Kinase Inhibitors
1
2007
94
0.140
Why?
Receptor, Epidermal Growth Factor
1
2007
95
0.140
Why?
Models, Biological
2
2007
1023
0.140
Why?
Phosphates
1
2007
154
0.140
Why?
Biological Markers
1
2009
564
0.140
Why?
Genes, p53
1
2006
51
0.140
Why?
Retinoblastoma Protein
2
2001
35
0.140
Why?
Adult
5
2008
11345
0.140
Why?
Cell Line, Tumor
4
2006
576
0.130
Why?
Enzyme Activation
1
2008
613
0.130
Why?
Anti-Inflammatory Agents
1
2007
116
0.130
Why?
Randomized Controlled Trials as Topic
1
2008
409
0.130
Why?
Epithelial Cells
1
2008
328
0.130
Why?
Retrospective Studies
1
2011
2260
0.130
Why?
Prognosis
1
2008
1080
0.130
Why?
Skin Neoplasms
1
2008
231
0.130
Why?
Cell Proliferation
1
2008
521
0.130
Why?
Phosphorylation
1
2008
833
0.120
Why?
Administration, Oral
3
2007
309
0.120
Why?
Pneumonia
1
2006
195
0.120
Why?
Intestinal Polyps
1
2002
15
0.110
Why?
Drug Resistance, Neoplasm
2
2008
56
0.090
Why?
Melanoma
1
2001
135
0.090
Why?
Neoplasm Metastasis
2
2008
229
0.080
Why?
Carrier Proteins
1
2002
434
0.080
Why?
Mutagenesis
1
1999
142
0.080
Why?
DNA Repair
1
1999
174
0.080
Why?
Phenotype
2
2006
762
0.060
Why?
DNA-Binding Proteins
1
1999
687
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2001
254
0.060
Why?
Demography
1
2011
97
0.050
Why?
Animals, Genetically Modified
1
2011
55
0.050
Why?
Genotype
1
2011
487
0.050
Why?
Chemokine CXCL12
1
2009
33
0.040
Why?
Cyclic S-Oxides
1
2009
1
0.040
Why?
Thiadiazoles
1
2009
13
0.040
Why?
Oncogene Protein v-akt
1
2008
4
0.040
Why?
Survival Analysis
1
2011
598
0.040
Why?
Cell Line, Transformed
1
2008
60
0.040
Why?
Neoplasm Staging
1
2010
335
0.040
Why?
Genomics
1
2008
48
0.040
Why?
Mice, Nude
1
2008
177
0.040
Why?
Combined Modality Therapy
1
2010
486
0.040
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
36
0.040
Why?
Neoplasm Invasiveness
1
2008
154
0.040
Why?
Survival Rate
1
2010
619
0.040
Why?
Transcription, Genetic
1
2012
815
0.040
Why?
Epidermis
1
2008
79
0.040
Why?
Cat Diseases
1
2007
2
0.040
Why?
Urinalysis
1
2007
18
0.040
Why?
Stromal Cells
1
2007
72
0.040
Why?
Young Adult
1
2011
1074
0.040
Why?
Urinary Calculi
1
2007
33
0.040
Why?
Cross-Over Studies
1
2007
126
0.040
Why?
Interleukin-6
1
2009
340
0.040
Why?
Alleles
1
2006
202
0.030
Why?
Homozygote
1
2006
90
0.030
Why?
Cell Movement
1
2008
376
0.030
Why?
Cyclooxygenase 2
1
2007
226
0.030
Why?
Mice, Inbred C57BL
1
2011
1683
0.030
Why?
Macrophages, Alveolar
1
2006
117
0.030
Why?
Stem Cells
1
2009
363
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2006
301
0.030
Why?
DNA Primers
1
2006
414
0.030
Why?
Cell Line
1
2009
1594
0.030
Why?
Time Factors
1
2011
3201
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
543
0.030
Why?
Magnetic Resonance Imaging
1
2009
1010
0.030
Why?
Child
1
2011
4086
0.030
Why?
Culture Media, Conditioned
1
2002
64
0.030
Why?
Gene Targeting
1
2002
69
0.030
Why?
Cell Aging
1
2002
57
0.030
Why?
Adolescent
1
2011
4752
0.030
Why?
Base Sequence
1
2006
1704
0.030
Why?
cdc25 Phosphatases
1
2001
1
0.020
Why?
S Phase
1
2001
41
0.020
Why?
G1 Phase
1
2001
48
0.020
Why?
Cyclin D1
1
2001
32
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2001
45
0.020
Why?
Gene Silencing
1
2001
40
0.020
Why?
Cyclins
1
2001
52
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2001
70
0.020
Why?
Cell Differentiation
1
2006
1098
0.020
Why?
In Situ Hybridization
1
2001
314
0.020
Why?
Xeroderma Pigmentosum Group A Protein
1
1999
2
0.020
Why?
Chimera
1
1999
34
0.020
Why?
Lac Operon
1
1999
60
0.020
Why?
Fibroblasts
1
2002
545
0.020
Why?
Genes, Reporter
1
1999
207
0.020
Why?
Proteins
1
2001
467
0.020
Why?
Age Factors
1
1999
1121
0.020
Why?
RNA, Messenger
1
2002
1857
0.020
Why?
Brain
1
1999
1221
0.010
Why?

Visualizations


Hezel's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department